Keyphrases
Cyclosporine
100%
Doxorubicin
100%
After Injection
100%
Eyelid Skin
100%
Eyelid
44%
Skin Injury
33%
Blepharospasm
22%
Injection Site
22%
Hemifacial Spasm
22%
Doxorubicin Treatments
22%
Inflammation
11%
Healing
11%
Dose-ranging
11%
High Dose
11%
Inflammatory Response
11%
Dose Effect
11%
Age of Onset
11%
Acute Inflammation
11%
Patient Acceptance
11%
Immunosuppressive Agents
11%
Cytokine Release
11%
Epithelial Damage
11%
Muscle Loss
11%
Myotoxic
11%
Muscle Fiber Loss
11%
Evans Blue
11%
Muscle Fiber number
11%
Anesthetized Rabbit
11%
Medicine and Dentistry
Injury
100%
Cyclosporine
100%
Doxorubicin
100%
Eyelid
100%
Skin Injury
27%
Serositis
18%
Injection Site
18%
Hemifacial Spasm
18%
Blepharospasm
18%
Drug Megadose
9%
Side Effect
9%
Morphometrics
9%
Skin Defect
9%
Cytokine Release
9%
Evans Blue
9%
Immunosuppressive Drug
9%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Ciclosporin
100%
Injury
100%
Leporidae
27%
Skin Injury
27%
Inflammation
27%
Hemifacial Spasm
18%
Blepharospasm
18%
Side Effect
9%
Cytokine
9%
Skin Defect
9%
Immunosuppressive Agent
9%
Evans Blue
9%
Nursing and Health Professions
Doxil
100%
Injury
100%
Ciclosporin
100%
Inflammation
27%
Skin Injury
27%
Injection Site
18%
Blepharospasm
18%
Hemifacial Spasm
18%
Immunosuppressive Agent
9%
Morphometry
9%
Drug Megadose
9%
Side Effect
9%
Skin Defect
9%
Evans Blue
9%
Neuroscience
Ciclosporin
100%
Eyelid
100%
Doxorubicin
100%
Blepharospasm
18%
Immunosuppressive Drug
9%
Veterinary Science and Veterinary Medicine